Ninety-four percent of respondents said that “medical marijuana should be legalized in all US states.”
Year: 2024
Since 1992, every Thursday and when breaking news warrants, NORML | The NORML Foundation have been issuing weekly press releases for marijuana law supporters and the media.
NORML’s News Releases archives goes back to 1996 and serves as a valuable tool to alert citizens about cannabis-related news and legislation as well as a research tool for reviewing a chronology of marijuana law reform.
“The rate of ∆8-THC exposures reported to poison control centers was significantly lower among states … where cannabis use was legal,” the study’s authors concluded.
“Consumers are unwittingly consuming contaminated products,” researchers reported.
“For patients receiving moderate- or high-emetic-risk chemotherapy, THC:CBD may be considered as an option.”
The study’s authors concluded, “Medical cannabis should be considered an alternative treatment for patients who suffer from anxiety, depression, insomnia, or chronic pain.”
Sixty-one percent of cannabis consumers say that it has a “positive” effect on “most people who use it.”
Consistent with prior studies, investigators concluded, “The correlation between drug concentration was high for ethanol, … but low for THC.”
Researchers concluded, “Cannabis co-use assisted in developing patterns of reduced opioid use in a number of ways.”